Report Detail
Global Serum Biomarkers Market Research Report 2019
- RnM3086006 |
- 09 March, 2019 |
- Global |
- 104 Pages |
- QYResearch |
- Pharma & Healthcare
Serum biomarkers are proteins generally detected in urine, blood, and other bodily fluids produced by malignant cells or in reaction to presence/absence of malignant cells. Preferably, biomarkers should have at least one or more than one of the following properties: prompt detection of cancer within high risk population, diagnosis of specific type of cancer, prediction in its growth, screen its treatment response, and detect early recurrence.
The global serum biomarkers market is projected to grow at a rapid pace in the next few years. Key drivers of the market are increase in the number of people suffering from different types of cancer and rise in the geriatric population. Increase in the cancer-afflicted population is anticipated to be another key driver of the market.
The global Serum Biomarkers market is valued at xx million US$ in 2018 is expected to reach xx million US$ by the end of 2025, growing at a CAGR of xx% during 2019-2025.
This report focuses on Serum Biomarkers volume and value at global level, regional level and company level. From a global perspective, this report represents overall Serum Biomarkers market size by analyzing historical data and future prospect. Regionally, this report focuses on several key regions: North America, Europe, China and Japan.
At company level, this report focuses on the production capacity, ex-factory price, revenue and market share for each manufacturer covered in this report.
The following manufacturers are covered:
Roche
Pfizer
Novartis
Abbott
BD
Merck
Eli Lilly
Agilent Technologies
Boehringer Ingelheim
AstraZeneca
Bristol-Myers Squibb
Novo Nordisk
Allergan
Gilead
Segment by Regions
North America
Europe
China
Japan
Segment by Type
Hepatocellular Carcinoma Serum Biomarkers
Lung Cancer Serum Biomarkers
Pancreatic & Biliary Tract Cancer Serum Biomarkers
Breast Cancer Serum Biomarkers
Glioblastoma Serum Biomarkers
Others
Segment by Application
Hospitals
Academic & Research Institutes
Ambulatory Surgical Centers
Others
Table of Contents
Executive Summary
1 Serum Biomarkers Market Overview
- 1.1 Product Overview and Scope of Serum Biomarkers
- 1.2 Serum Biomarkers Segment by Type
- 1.2.1 Global Serum Biomarkers Production Growth Rate Comparison by Type (2014-2025)
- 1.2.2 Hepatocellular Carcinoma Serum Biomarkers
- 1.2.3 Lung Cancer Serum Biomarkers
- 1.2.4 Pancreatic & Biliary Tract Cancer Serum Biomarkers
- 1.2.5 Breast Cancer Serum Biomarkers
- 1.2.6 Glioblastoma Serum Biomarkers
- 1.2.7 Others
- 1.3 Serum Biomarkers Segment by Application
- 1.3.1 Serum Biomarkers Consumption Comparison by Application (2014-2025)
- 1.3.2 Hospitals
- 1.3.3 Academic & Research Institutes
- 1.3.4 Ambulatory Surgical Centers
- 1.3.5 Others
- 1.4 Global Serum Biomarkers Market by Region
- 1.4.1 Global Serum Biomarkers Market Size Region
- 1.4.2 North America Status and Prospect (2014-2025)
- 1.4.3 Europe Status and Prospect (2014-2025)
- 1.4.4 China Status and Prospect (2014-2025)
- 1.4.5 Japan Status and Prospect (2014-2025)
- 1.5 Global Serum Biomarkers Market Size
- 1.5.1 Global Serum Biomarkers Revenue (2014-2025)
- 1.5.2 Global Serum Biomarkers Production (2014-2025)
2 Global Serum Biomarkers Market Competition by Manufacturers
- 2.1 Global Serum Biomarkers Production Market Share by Manufacturers (2014-2019)
- 2.2 Global Serum Biomarkers Revenue Share by Manufacturers (2014-2019)
- 2.3 Global Serum Biomarkers Average Price by Manufacturers (2014-2019)
- 2.4 Manufacturers Serum Biomarkers Production Sites, Area Served, Product Types
- 2.5 Serum Biomarkers Market Competitive Situation and Trends
- 2.5.1 Serum Biomarkers Market Concentration Rate
- 2.5.2 Serum Biomarkers Market Share of Top 3 and Top 5 Manufacturers
- 2.5.3 Mergers & Acquisitions, Expansion
3 Global Serum Biomarkers Production Market Share by Regions
- 3.1 Global Serum Biomarkers Production Market Share by Regions
- 3.2 Global Serum Biomarkers Revenue Market Share by Regions (2014-2019)
- 3.3 Global Serum Biomarkers Production, Revenue, Price and Gross Margin (2014-2019)
- 3.4 North America Serum Biomarkers Production
- 3.4.1 North America Serum Biomarkers Production Growth Rate (2014-2019)
- 3.4.2 North America Serum Biomarkers Production, Revenue, Price and Gross Margin (2014-2019)
- 3.5 Europe Serum Biomarkers Production
- 3.5.1 Europe Serum Biomarkers Production Growth Rate (2014-2019)
- 3.5.2 Europe Serum Biomarkers Production, Revenue, Price and Gross Margin (2014-2019)
- 3.6 China Serum Biomarkers Production (2014-2019)
- 3.6.1 China Serum Biomarkers Production Growth Rate (2014-2019)
- 3.6.2 China Serum Biomarkers Production, Revenue, Price and Gross Margin (2014-2019)
- 3.7 Japan Serum Biomarkers Production (2014-2019)
- 3.7.1 Japan Serum Biomarkers Production Growth Rate (2014-2019)
- 3.7.2 Japan Serum Biomarkers Production, Revenue, Price and Gross Margin (2014-2019)
4 Global Serum Biomarkers Consumption by Regions
- 4.1 Global Serum Biomarkers Consumption by Regions
- 4.2 North America Serum Biomarkers Consumption (2014-2019)
- 4.3 Europe Serum Biomarkers Consumption (2014-2019)
- 4.4 China Serum Biomarkers Consumption (2014-2019)
- 4.5 Japan Serum Biomarkers Consumption (2014-2019)
5 Global Serum Biomarkers Production, Revenue, Price Trend by Type
- 5.1 Global Serum Biomarkers Production Market Share by Type (2014-2019)
- 5.2 Global Serum Biomarkers Revenue Market Share by Type (2014-2019)
- 5.3 Global Serum Biomarkers Price by Type (2014-2019)
- 5.4 Global Serum Biomarkers Production Growth by Type (2014-2019)
6 Global Serum Biomarkers Market Analysis by Applications
- 6.1 Global Serum Biomarkers Consumption Market Share by Application (2014-2019)
- 6.2 Global Serum Biomarkers Consumption Growth Rate by Application (2014-2019)
7 Company Profiles and Key Figures in Serum Biomarkers Business
- 7.1 Roche
- 7.1.1 Roche Serum Biomarkers Production Sites and Area Served
- 7.1.2 Serum Biomarkers Product Introduction, Application and Specification
- 7.1.3 Roche Serum Biomarkers Production, Revenue, Price and Gross Margin (2014-2019)
- 7.1.4 Main Business and Markets Served
- 7.2 Pfizer
- 7.2.1 Pfizer Serum Biomarkers Production Sites and Area Served
- 7.2.2 Serum Biomarkers Product Introduction, Application and Specification
- 7.2.3 Pfizer Serum Biomarkers Production, Revenue, Price and Gross Margin (2014-2019)
- 7.2.4 Main Business and Markets Served
- 7.3 Novartis
- 7.3.1 Novartis Serum Biomarkers Production Sites and Area Served
- 7.3.2 Serum Biomarkers Product Introduction, Application and Specification
- 7.3.3 Novartis Serum Biomarkers Production, Revenue, Price and Gross Margin (2014-2019)
- 7.3.4 Main Business and Markets Served
- 7.4 Abbott
- 7.4.1 Abbott Serum Biomarkers Production Sites and Area Served
- 7.4.2 Serum Biomarkers Product Introduction, Application and Specification
- 7.4.3 Abbott Serum Biomarkers Production, Revenue, Price and Gross Margin (2014-2019)
- 7.4.4 Main Business and Markets Served
- 7.5 BD
- 7.5.1 BD Serum Biomarkers Production Sites and Area Served
- 7.5.2 Serum Biomarkers Product Introduction, Application and Specification
- 7.5.3 BD Serum Biomarkers Production, Revenue, Price and Gross Margin (2014-2019)
- 7.5.4 Main Business and Markets Served
- 7.6 Merck
- 7.6.1 Merck Serum Biomarkers Production Sites and Area Served
- 7.6.2 Serum Biomarkers Product Introduction, Application and Specification
- 7.6.3 Merck Serum Biomarkers Production, Revenue, Price and Gross Margin (2014-2019)
- 7.6.4 Main Business and Markets Served
- 7.7 Eli Lilly
- 7.7.1 Eli Lilly Serum Biomarkers Production Sites and Area Served
- 7.7.2 Serum Biomarkers Product Introduction, Application and Specification
- 7.7.3 Eli Lilly Serum Biomarkers Production, Revenue, Price and Gross Margin (2014-2019)
- 7.7.4 Main Business and Markets Served
- 7.8 Agilent Technologies
- 7.8.1 Agilent Technologies Serum Biomarkers Production Sites and Area Served
- 7.8.2 Serum Biomarkers Product Introduction, Application and Specification
- 7.8.3 Agilent Technologies Serum Biomarkers Production, Revenue, Price and Gross Margin (2014-2019)
- 7.8.4 Main Business and Markets Served
- 7.9 Boehringer Ingelheim
- 7.9.1 Boehringer Ingelheim Serum Biomarkers Production Sites and Area Served
- 7.9.2 Serum Biomarkers Product Introduction, Application and Specification
- 7.9.3 Boehringer Ingelheim Serum Biomarkers Production, Revenue, Price and Gross Margin (2014-2019)
- 7.9.4 Main Business and Markets Served
- 7.10 AstraZeneca
- 7.10.1 AstraZeneca Serum Biomarkers Production Sites and Area Served
- 7.10.2 Serum Biomarkers Product Introduction, Application and Specification
- 7.10.3 AstraZeneca Serum Biomarkers Production, Revenue, Price and Gross Margin (2014-2019)
- 7.10.4 Main Business and Markets Served
- 7.11 Bristol-Myers Squibb
- 7.12 Novo Nordisk
- 7.13 Allergan
- 7.14 Gilead
8 Serum Biomarkers Manufacturing Cost Analysis
- 8.1 Serum Biomarkers Key Raw Materials Analysis
- 8.1.1 Key Raw Materials
- 8.1.2 Price Trend of Key Raw Materials
- 8.1.3 Key Suppliers of Raw Materials
- 8.2 Proportion of Manufacturing Cost Structure
- 8.3 Manufacturing Process Analysis of Serum Biomarkers
- 8.4 Serum Biomarkers Industrial Chain Analysis
9 Marketing Channel, Distributors and Customers
- 9.1 Marketing Channel
- 9.1.1 Direct Marketing
- 9.1.2 Indirect Marketing
- 9.2 Serum Biomarkers Distributors List
- 9.3 Serum Biomarkers Customers
10 Market Dynamics
- 10.1 Market Trends
- 10.2 Opportunities
- 10.3 Market Drivers
- 10.4 Challenges
- 10.5 Influence Factors
11 Global Serum Biomarkers Market Forecast
- 11.1 Global Serum Biomarkers Production, Revenue Forecast
- 11.1.1 Global Serum Biomarkers Production Growth Rate Forecast (2019-2025)
- 11.1.2 Global Serum Biomarkers Revenue and Growth Rate Forecast (2019-2025)
- 11.1.3 Global Serum Biomarkers Price and Trend Forecast (2019-2025)
- 11.2 Global Serum Biomarkers Production Forecast by Regions (2019-2025)
- 11.2.1 North America Serum Biomarkers Production, Revenue Forecast (2019-2025)
- 11.2.2 Europe Serum Biomarkers Production, Revenue Forecast (2019-2025)
- 11.2.3 China Serum Biomarkers Production, Revenue Forecast (2019-2025)
- 11.2.4 Japan Serum Biomarkers Production, Revenue Forecast (2019-2025)
- 11.3 Global Serum Biomarkers Consumption Forecast by Regions (2019-2025)
- 11.3.1 North America Serum Biomarkers Consumption Forecast (2019-2025)
- 11.3.2 Europe Serum Biomarkers Consumption Forecast (2019-2025)
- 11.3.3 China Serum Biomarkers Consumption Forecast (2019-2025)
- 11.3.4 Japan Serum Biomarkers Consumption Forecast (2019-2025)
- 11.4 Global Serum Biomarkers Production, Revenue and Price Forecast by Type (2019-2025)
- 11.5 Global Serum Biomarkers Consumption Forecast by Application (2019-2025)
12 Research Findings and Conclusion
13 Methodology and Data Source
- 13.1 Methodology/Research Approach
- 13.1.1 Research Programs/Design
- 13.1.2 Market Size Estimation
- 13.1.3 Market Breakdown and Data Triangulation
- 13.2 Data Source
- 13.2.1 Secondary Sources
- 13.2.2 Primary Sources
- 13.3 Author List
Summary:
Get latest Market Research Reports on Serum Biomarkers. Industry analysis & Market Report on Serum Biomarkers is a syndicated market report, published as Global Serum Biomarkers Market Research Report 2019. It is complete Research Study and Industry Analysis of Serum Biomarkers market, to understand, Market Demand, Growth, trends analysis and Factor Influencing market.
REPORT YOU MIGHT BE INTERESTED
Related Reports
Reason to Buy
Reports and Markets
Contact Us
+1-352-353-0818 (US)Newsletter
KEEP UP TO DATE ON ALL THE LATEST REPORTS
